why choose us

First received: August 09, 2023

Clinical Trial: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PB-718 Injection in Chinese Obese Subjects.

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Obesity

Study Type: INTERVENTIONAL


Official Title: A Single Center, Randomized, Double Blind, Placebo Controlled, Multiple Dose Escalating Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PB-718 Injection in Chinese Obese Subjects.

Brief Summary: The trial is conducted in a single center, randomized, double blind, placebo controlled, dose increasing design.To evaluate the safety, tolerability, pharmacokinetics(PK) characteristics, efficacy and immunogenicity of PB-718 injection in Chinese obese subjects.

Read more